Il y a eu 50 transactions d'initiés récentes enregistrées pour Schrödinger, Inc. (SDGR), dont 25 achats et 21 ventes. Le total des achats d'initiés s'élève à $5.35M et le total des ventes d'initiés à $395.08K.
Les initiés notables ayant une activité récente comprennent Abrams Therese Marie, Herman Jenny, Akinsanya Karen. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SDGR
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-08 |
Abrams Therese Marie |
VP, Corporate Controller |
Inconnu |
5,980 |
$12.15 |
$72.66K |
- |
| 2026-03-06 |
Herman Jenny |
CAO |
Vente Informative |
608 |
$12.84 |
$7.81K |
34,804 |
| 2026-03-05 |
Akinsanya Karen |
See Remarks |
Vente Informative |
1,366 |
$12.90 |
$17.63K |
69,956 |
| 2026-03-05 |
Farid Ramy |
President & CEO |
Vente Informative |
3,661 |
$12.91 |
$47.25K |
330,824 |
| 2026-03-05 |
Lorton Kenneth Patrick |
EVP, CTO & COO, Software |
Vente Informative |
1,222 |
$12.90 |
$15.76K |
89,241 |
| 2026-03-05 |
Tran Yvonne |
EVP, CLO & CPO |
Vente Informative |
1,094 |
$12.90 |
$14.11K |
52,683 |
| 2026-03-05 |
Herman Jenny |
CAO |
Vente Informative |
775 |
$12.85 |
$9.96K |
35,412 |
| 2026-03-05 |
Jain Rachit |
EVP & CFO |
Vente Informative |
1,631 |
$12.90 |
$21.03K |
52,596 |
| 2026-03-04 |
Abel Robert Lorne |
See Remarks |
Vente Informative |
1,300 |
$12.81 |
$16.65K |
55,897 |
| 2026-02-10 |
Lorton Kenneth Patrick |
EVP, CTO & COO, Software |
Vente Informative |
925 |
$13.73 |
$12.7K |
52,651 |
| 2026-02-10 |
Tran Yvonne |
EVP, CLO & CPO |
Vente Informative |
776 |
$13.80 |
$10.71K |
22,859 |
| 2026-02-10 |
Herman Jenny |
CAO |
Vente Informative |
752 |
$13.79 |
$10.37K |
26,597 |
| 2026-02-09 |
Abel Robert Lorne |
See Remarks |
Vente Informative |
1,230 |
$13.51 |
$16.62K |
19,385 |
| 2025-10-16 |
Dugan Margaret |
Chief Medical Officer |
Vente Informative |
1,395 |
$21.07 |
$29.39K |
24,574 |
| 2025-06-18 |
Ginsberg Gary L |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Oberoi Arun |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Van Kralingen Bridget A |
Director |
Attribution de RSU |
2,335 |
$21.05 |
$49.15K |
2,335 |
| 2025-06-18 |
Lynton Michael |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Chodakewitz Jeffrey |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Sender Gary |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Thornberry Nancy |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Kapeller-libermann Rosana |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-06-18 |
Friesner Richard |
Director |
Attribution de RSU |
9,341 |
$21.05 |
$196.63K |
9,341 |
| 2025-05-29 |
Aklian Mannix Vartan |
See Remarks |
Attribution de RSU |
14,063 |
- |
- |
14,063 |
| 2025-05-28 |
Aklian Mannix Vartan |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-05-21 |
Jain Rachit |
EVP & CFO |
Attribution de RSU |
18,750 |
$20.51 |
$384.56K |
18,750 |
| 2025-05-16 |
Jain Rachit |
EVP & CFO |
Inconnu |
35,000 |
$26.04 |
$911.4K |
- |
| 2025-04-14 |
Akinsanya Karen |
President of R&d, Therapeutics |
Exercice d'Options (Vente) |
3,345 |
$2.92 |
$9.77K |
- |
| 2025-03-07 |
Van Kralingen Bridget A |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-03-07 |
Van Kralingen Bridget A |
Director |
Attribution de RSU |
10,000 |
- |
- |
10,000 |
| 2025-03-06 |
Herman Jenny |
SVP & Controller |
Vente Informative |
666 |
$21.11 |
$14.06K |
27,349 |
| 2025-03-03 |
Akinsanya Karen |
President of R&d, Therapeutics |
Attribution de RSU |
15,625 |
- |
- |
15,625 |
| 2025-03-03 |
Farid Ramy |
President & CEO |
Attribution de RSU |
60,000 |
$21.24 |
$1.27M |
60,000 |
| 2025-03-03 |
Lorton Kenneth Patrick |
EVP, CTO & COO, Software |
Attribution de RSU |
50,000 |
$21.24 |
$1.06M |
50,000 |
| 2025-03-03 |
Tran Yvonne |
EVP, CLO & CPO |
Attribution de RSU |
12,500 |
- |
- |
23,635 |
| 2025-03-03 |
Herman Jenny |
SVP & Controller |
Attribution de RSU |
8,400 |
$21.24 |
$178.42K |
8,400 |
| 2025-03-03 |
Abel Robert Lorne |
See Remarks |
Attribution de RSU |
12,500 |
- |
- |
20,615 |
| 2025-03-03 |
Dugan Margaret |
Chief Medical Officer |
Attribution de RSU |
12,500 |
- |
- |
25,969 |
| 2025-03-03 |
Porges Geoffrey Craig |
EVP & CFO |
Attribution de RSU |
12,500 |
- |
- |
18,185 |
| 2025-02-18 |
Tran Yvonne |
EVP, CLO & CPO |
Exercice d'Options (Vente) |
3,902 |
$4.34 |
$16.93K |
- |
| 2025-02-11 |
Lorton Kenneth Patrick |
EVP, CTO & COO, Software |
Vente Informative |
985 |
$24.43 |
$24.06K |
41,076 |
| 2025-02-11 |
Tran Yvonne |
EVP, CLO & CPO |
Vente Informative |
828 |
$24.43 |
$20.23K |
11,135 |
| 2025-02-11 |
Herman Jenny |
SVP & Controller |
Vente Informative |
859 |
$24.43 |
$20.99K |
18,215 |
| 2025-02-10 |
Abel Robert Lorne |
See Remarks |
Vente Informative |
1,225 |
$25.99 |
$31.84K |
8,115 |
| 2024-10-15 |
Dugan Margaret |
Chief Medical Officer |
Vente Informative |
1,531 |
$17.78 |
$27.23K |
13,469 |
| 2024-06-18 |
Ginsberg Gary L |
Director |
Attribution de RSU |
8,550 |
$19.32 |
$165.19K |
8,550 |
| 2024-06-18 |
Oberoi Arun |
Director |
Attribution de RSU |
8,550 |
$19.32 |
$165.19K |
8,550 |
| 2024-06-18 |
Lynton Michael |
Director |
Attribution de RSU |
8,550 |
$19.32 |
$165.19K |
8,550 |
| 2024-06-18 |
Chodakewitz Jeffrey |
Director |
Attribution de RSU |
8,550 |
$19.32 |
$165.19K |
8,550 |
| 2024-06-18 |
Sender Gary |
Director |
Attribution de RSU |
8,550 |
$19.32 |
$165.19K |
8,550 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
